CJC-1295 and Ipamorelin are commonly combined because they stimulate the body’s natural release of growth hormone (GH) through two different pathways. Rather than supplying growth hormone directly, the combination is designed around encouraging the pituitary gland to release more of its own.
CJC-1295 No DAC acts like GHRH (growth hormone-releasing hormone), which signals the pituitary gland to release growth hormone. Ipamorelin works through the ghrelin receptor, providing a second signal for GH release.
In simple terms: CJC-1295 provides one signal telling the pituitary to release growth hormone, while Ipamorelin provides another through a different receptor. This is the main reason the two peptides are so commonly paired.
CJC-1295 Ipamorelin Benefits
Most interest in the combination centres around recovery, muscle development, body composition and sleep.
Recovery & Muscle
Recovery is one of the biggest reasons CJC-1295 and Ipamorelin are discussed in training and peptide communities.
- Workout recovery
- Muscle development
- Training recovery
- Maintaining lean mass
Body Composition
The growth hormone and IGF-1 pathway is also why people are interested in the combination for:
- Lean body mass
- Fat metabolism
- Overall body composition
Sleep & Recovery
Sleep is another major theme in user discussions, particularly when the combination is used around bedtime.
- Deeper sleep
- Night-time recovery
- Feeling better recovered
Why Combine CJC-1295 and Ipamorelin?
The attraction isn’t simply having two growth-hormone peptides in the same vial. They stimulate GH release through two different receptors.
CJC-1295 No DAC
Mimics the action of GHRH, the hormone the body naturally uses to signal the pituitary gland to release growth hormone.
Ipamorelin
Activates the ghrelin receptor, providing another signal that stimulates the release of growth hormone.
Using the two together is intended to create a stronger short GH pulse than targeting either pathway alone. This pulse-based approach is one reason the CJC-1295 No DAC + Ipamorelin combination has become popular.
What Does the Research Show?
Research supports the basic mechanism behind both peptide types. GHRH-type peptides stimulate growth hormone release through the GHRH receptor, while Ipamorelin stimulates GH release through the ghrelin receptor.
Human research has shown that Ipamorelin can produce a distinct growth-hormone pulse.
Human clinical research on the exact CJC-1295 No DAC + Ipamorelin combination remains limited. Much of the published human research involving CJC-1295 used the longer-acting DAC version, so those results should not simply be treated as trials of the No-DAC combination.
CJC-1295 Ipamorelin Dosage
There is no established clinical dosing protocol for this combination. Looking at protocols commonly discussed online, doses are often described in terms of the amount of each peptide per dose.
Lower Protocol
Around 100 mcg CJC-1295 + 100 mcg Ipamorelin per dose is commonly discussed as a lower protocol.
Common Protocol
Around 200 mcg of each peptide once daily is another frequently discussed approach, particularly around bedtime.
Higher Protocol
Protocols around 250 mcg of each peptide per dose are also discussed in peptide and bodybuilding communities.
CJC-1295 Ipamorelin Dosage Per Day
Once-daily use is commonly discussed, particularly with CJC-1295 No DAC because of its short-acting nature. Other protocols split use into more than one daily dose in an attempt to create separate GH pulses.
Bodybuilding protocols commonly discussed online generally follow the same idea: relatively small amounts are used to create a pulse rather than trying to maintain continuously elevated levels throughout the day.
Important: these are examples of protocols commonly discussed by peptide users, vendors and practitioners online. They are not clinically established dosing recommendations for CJC-1295 No DAC + Ipamorelin.
When Do People Take CJC-1295 + Ipamorelin?
Before bed is probably the most commonly discussed timing. This fits with the body’s naturally strong night-time growth-hormone pulses and helps explain why sleep and overnight recovery feature heavily in user discussions.
Commonly discussed approaches include:
- Once daily before bed
- Around 30–60 minutes before sleep
- Using it away from a large meal
- Protocols that include days off during the week
CJC-1295 Ipamorelin Results: What Do People Report?
Searches for CJC-1295 Ipamorelin often include terms such as results, before and after and results timeline. Most of the information available here comes from individual user experiences rather than controlled clinical trials of the combination.
Early Reports
Sleep and recovery are among the changes people most commonly describe noticing first. Some users report deeper sleep or feeling better recovered after training.
Longer-Term Reports
Changes in body composition, recovery and training performance are more commonly discussed over longer periods rather than as immediate effects.
Results reported online are mixed. Some people describe noticeable changes in sleep, recovery or body composition, while others report relatively subtle effects. There isn’t a reliable clinical “before and after” timeline for the CJC-1295 No DAC + Ipamorelin combination.
CJC-1295 No DAC vs CJC-1295 With DAC
This distinction is important because the two versions behave very differently in the body.
CJC-1295 No DAC
The short-acting version commonly associated with Modified GRF (1-29). It is used when a shorter, pulse-like GH response is wanted.
- Short acting
- Pulse-based GH release
- Commonly paired with Ipamorelin
CJC-1295 With DAC
DAC stands for Drug Affinity Complex. It allows the peptide to bind to albumin in the blood, dramatically extending its activity.
- Long acting
- Activity lasting for days
- More sustained GH and IGF-1 activity
The No DAC version is the one commonly paired with Ipamorelin when the goal is to produce shorter GH pulses rather than prolonged stimulation.
CJC-1295 Ipamorelin Side Effects
Experiences vary considerably. Some users report very little, while others notice temporary effects shortly after using the combination.
Side effects discussed by users include:
- Flushing or feeling warm
- Headaches
- Water retention
- Fatigue or morning grogginess
- Injection-site irritation
- Changes in sleep
Sleep experiences are particularly mixed. Some users describe noticeably deeper sleep, while others report waking early or feeling groggy the following morning.
CJC-1295 + Ipamorelin FAQs
Why are CJC-1295 and Ipamorelin used together?
They stimulate growth hormone through different receptors. CJC-1295 No DAC works through the GHRH pathway while Ipamorelin works through the ghrelin receptor, which is why the two are commonly combined.
Is CJC-1295 No DAC the same as CJC-1295 with DAC?
No. The No-DAC form is short acting and is used for a more pulse-like response. Adding DAC dramatically extends CJC-1295’s activity.
How long does CJC-1295 No DAC last?
CJC-1295 No DAC is short acting compared with the DAC version. This short duration is one of the reasons it is commonly paired with Ipamorelin in pulse-based protocols.
Does CJC-1295 Ipamorelin help with sleep?
Improved sleep is frequently mentioned in user reports, particularly with bedtime use. Experiences differ, however, and some people instead report disturbed sleep or morning grogginess.
Does CJC-1295 Ipamorelin increase growth hormone?
Both peptides are designed around stimulating growth-hormone release. CJC-1295 targets the GHRH pathway while Ipamorelin activates the ghrelin receptor.
How long does it take to see results?
There is no established results timeline. Anecdotally, sleep and recovery are often discussed as earlier changes, while body-composition changes are generally discussed over a longer period.